SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-174740
Filing Date
2019-06-17
Accepted
2019-06-18 14:56:39
Documents
2
Group Members
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D d724948dsc13d.htm SC 13D 73304
2 EX-99.1 d724948dex991.htm EX-99.1 4367
  Complete submission text file 0001193125-19-174740.txt   79435
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Subject) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79588 | Film No.: 19903534
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O ONCTERNAL THERAPEUTICS, INC. 3525 DEL MAR HEIGHTS ROAD #821 SAN DIEGO CA 92130-2122
Business Address C/O ONCTERNAL THERAPEUTICS, INC. 3525 DEL MAR HEIGHTS ROAD #821 SAN DIEGO CA 92130-2122 (858) 434-1113
Shanghai Pharmaceutical (USA) Inc. (Filed by) CIK: 0001778270 (see all company filings)

IRS No.: 841672973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D